The Ghana AIDS Commission has announced its plan to introduce a HIV preventive drug in 2026 as a strategic measure to curb the spread of the virus across the country.
The decision comes in response to alarming data, which indicates that Ghana recorded more than 15,000 new HIV infections in the past year.
Dr. Prosper Akanbong, Director-General of the Commission, commented that the 2026 rollout of the preventive medication will serve a dual purpose: it will strengthen national prevention efforts while simultaneously helping to build local capacity for pharmaceutical production.
Dr. Akanbong further disclosed that the Commission has already initiated discussions with pharmaceutical companies, supported by the German Agency for International Cooperation (GIZ), to ensure a sustainable and effective rollout of the drug.
“As a country, we have already put the vaccine as a main component of our HIV prevention programme. Initially, we will secure it from outside, but with the pharmacy organisations that you see here, they have positioned themselves to be able to produce the vaccines locally,” Dr. Akanbong explained.
“Together with GIZ, we are on track, and in the latter part of 2026 or the early part of 2027, we should be able to produce vaccines for Ghana,” he added.
By: Rainbowradioonline.com/Ghana
